Insufficient Knowledge and Vaccination Practice of Inflammatory Bowel Disease Patients in the People's Republic of China

References

• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46–54 e42. doi:10.1053/j.gastro.2011.10.001
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A. A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease. Front Med. 2018;5:183. doi:10.3389/fmed.2018.00183
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0
   PubMed Web of Science ®Google Scholar
• Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8(6):443–468. doi:10.1016/j.crohns.2013.12.013
   PubMed Web of Science ®Google Scholar
• Ford AC, Peyrin-Biroulet L. Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2013;108(8):1268–1276. doi:10.1038/ajg.2013.138
   PubMed Web of Science ®Google Scholar
• Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101(8):1834–1840. doi:10.1111/j.1572-0241.2006.00646.x
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed August 7, 2020.
   Google Scholar
• Loras C, Gisbert JP, Mínguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59(10):1340–1346. doi:10.1136/gut.2010.208413
   PubMed Web of Science ®Google Scholar
• Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol. 2017;112(2):241–258. doi:10.1038/ajg.2016.537
   PubMed Web of Science ®Google Scholar
• Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohns Colitis. 2015;9(6):439–444. doi:10.1093/ecco-jcc/jjv064
   Web of Science ®Google Scholar
• Ben Musa R, Gampa A, Basu S, et al. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014;20(41):15358–15366. doi:10.3748/wjg.v20.i41.15358
   PubMed Web of Science ®Google Scholar
• Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol. 2009;104(1):57–63. doi:10.1038/ajg.2008.4
   PubMed Web of Science ®Google Scholar
• Tsai SY, Yang TY, Lin CL, Tsai YH, Kuo CF, Kao CH. Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study. Int J Clin Pract. 2015;69(2):228–234. doi:10.1111/ijcp.12508
   Web of Science ®Google Scholar
• Chen Y. Perspectives of IBD China: is Crohn’s and colitis foundation model a solution to health care issues for the country? Inflamm Bowel Dis. 2018;24(5):925–929. doi:10.1093/ibd/izy056
   Web of Science ®Google Scholar
• Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231–1238. doi:10.1038/ajg.2009.733
   PubMed Web of Science ®Google Scholar
• Dezfoli S, Melmed GY. Vaccination issues in patients with inflammatory bowel disease receiving immunosuppression. Gastroenterol Hepatol (N Y). 2012;8(8):504–512.
   Google Scholar
• Catalán-Serra I, Huguet-Malavés JM, Mínguez M, et al. Information resources used by patients with inflammatory bowel disease: satisfaction, expectations and information gaps. Gastroenterol Hepatol. 2015;38(6):355–363. doi:10.1016/j.gastrohep.2014.09.003
   Web of Science ®Google Scholar
• Närhi U. Sources of medicine information and their reliability evaluated by medicine users. Pharm World Sci. 2007;29(6):688–694. doi:10.1007/s11096-007-9131-1
   Google Scholar
• Yu Q, Xu L, Li L, et al. Internet and WeChat used by patients with Crohn’s disease in China: a multi-center questionnaire survey. BMC Gastroenterol. 2019;19(1):97. doi:10.1186/s12876-019-1011-3
   PubMed Web of Science ®Google Scholar
• Martín Fernández C, Maroto Martín C, Fernández Salazar L. Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information. Rev Esp Enferm Apar Dig. 2018;110(5):274–284. doi:10.17235/reed.2018.5331/2017
   Google Scholar
• Chen D, Luo S, Ben Q, Lu L, Wan X, Wu J. Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China. Eur J Gastroenterol Hepatol. 2017;29(5):509–515. doi:10.1097/MEG.0000000000000838
   Web of Science ®Google Scholar
• Cullen G, Baden RP, Cheifetz AS. Varicella zoster virus infection in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2392–2403. doi:10.1002/ibd.22950
   PubMed Web of Science ®Google Scholar
• Khan N, Trivedi C, Kavani H, Lewis J, Yang YX. Frequency of herpes zoster vaccination among inflammatory bowel disease patients. Inflamm Bowel Dis. 2019;25(2):345–351. doi:10.1093/ibd/izy232
   Web of Science ®Google Scholar
• Yun HS, Min YW, Chang DK, et al. Factors associated with vaccination among inflammatory bowel disease patients in Korea. Korean J Gastroenterol. 2013;61(4):203–208. doi:10.4166/kjg.2013.61.4.203
   Google Scholar
• Xiang H, Tang XJ, Xiao M, et al. Study on status and willingness towards hepatitis B vaccination among migrant workers in chongqing, china: a cross-sectional study. Int J Env Res Pub He. 2019;16(20). doi:10.3390/ijerph16204046.
   Web of Science ®Google Scholar
• Liang X, Cui F, Hadler S, et al. Origins, design and implementation of the China GAVI project. Vaccine. 2013;31(Suppl 9):J8–14. doi:10.1016/j.vaccine.2012.12.019
   Web of Science ®Google Scholar
• Li SY, Li PW, Shen B, et al. Insufficient awareness and vaccination practices for inflammatory bowel disease patients in China: a multi-center survey of Chinese gastroenterologists. J Dig Dis. 2020;21(1):46–51. doi:10.1111/1751-2980.12834
   PubMed Web of Science ®Google Scholar
• Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17(12):2536–2540. doi:10.1002/ibd.21667
   PubMed Web of Science ®Google Scholar
• Christensen KR, Steenholdt C, Buhl SS, Ainsworth MA, Thomsen O, Brynskov J. Systematic information to health-care professionals about vaccination guidelines improves adherence in patients with inflammatory bowel disease in anti-TNFα therapy. Am J Gastroenterol. 2015;110(11):1526–1532. doi:10.1038/ajg.2015.162
   PubMed Web of Science ®Google Scholar